| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| SGI-1776 free base; SGI-1776 free base | CFN60248 | 1025065-69-3 | C20H22F3N5O = 405.42 | 5mg | QQ客服：3257982914 |
| BMS-777607; BMS-777607 | CFN60249 | 1025720-94-8 | C25H19ClF2N4O4 = 512.89 | 5mg | QQ客服：3257982914 |
| Lomibuvir (VX-222); Lomibuvir (VX-222) | CFN60250 | 1026785-59-0 | C25H35NO4S = 445.61 | 5mg | QQ客服：215959384 |
| 卡马替尼; Capmatinib (INCB28060) | CFN60251 | 1029712-80-8 | C23H17FN6O = 412.42 | 5mg | QQ客服：215959384 |
| 达托霉素; Daptomycin | CFN60252 | 103060-53-3 | C72H101N17O26 = 1620.67 | 5mg | QQ客服：1457312923 |
| 库潘尼西; Copanlisib (BAY 80-6946) | CFN60253 | 1032568-63-0 | C23H28N8O4 = 480.52 | 5mg | QQ客服：1457312923 |
| Apitolisib; Apitolisib (GDC-0980) | CFN60254 | 1032754-93-0 | C23H30N8O3S = 498.6 | 5mg | QQ客服：215959384 |
| TAK-733; TAK-733 | CFN60255 | 1035555-63-5 | C17H15F2IN4O4 = 504.23 | 5mg | QQ客服：3257982914 |
| Momelotinib; Momelotinib (CYT387) | CFN60256 | 1056634-68-4 | C23H22N6O2 = 414.46 | 5mg | QQ客服：1413575084 |
| Omipalisib (GSK2126458); Omipalisib (GSK2126458) | CFN60257 | 1086062-66-9 | C25H17F2N5O3S = 505.5 | 5mg | QQ客服：2056216494 |
| GSK1904529A; GSK1904529A | CFN60258 | 1089283-49-7 | C44H47F2N9O5S = 851.96 | 5mg | QQ客服：1413575084 |
| 盐酸二甲双胍; Metformin HCl | CFN60259 | 1115-70-4 | C4H11N5.HCl = 165.62 | 20mg | QQ客服：2159513211 |
| GSK1838705A; GSK1838705A | CFN60260 | 1116235-97-2 | C27H29FN8O3 = 532.57 | 5mg | QQ客服：1413575084 |
| N-乙酰基二醛; Tacedinaline (CI994) | CFN60261 | 112522-64-2 | C15H15N3O2 = 269.3 | 5mg | QQ客服：2056216494 |
| 来曲唑; Letrozole | CFN60262 | 112809-51-5 | C17H11N5 = 285.3 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)